PlainRecalls
FDA Drug Critical Class I Terminated

Phenytoin Oral Suspension USP, 125 mg/5 mL potency, 8 fl oz (237 mL) Rx Only Mfd. by: Taro Pharmaceuticals Industries Ltd. Haifa Bay, Israel 2624761 Dist. by: Taro Pharmaceuticals U.S.A. Inc. Hawthorne, NY 10532, NDC 51672-4069-1

Reported: March 4, 2020 Initiated: February 7, 2020 #D-0863-2020

Product Description

Phenytoin Oral Suspension USP, 125 mg/5 mL potency, 8 fl oz (237 mL) Rx Only Mfd. by: Taro Pharmaceuticals Industries Ltd. Haifa Bay, Israel 2624761 Dist. by: Taro Pharmaceuticals U.S.A. Inc. Hawthorne, NY 10532, NDC 51672-4069-1

Reason for Recall

Resuspension Problems: Two lots of Phenytoin Oral Suspension USP 125mg/5mL may coagulate and may not resuspend as per the label copy instructions.

Details

Units Affected
29,172 8 Fl Oz bottles
Distribution
Distributed Nationwide in the USA.
Location
Hawthorne, NY

Frequently Asked Questions

What product was recalled?
Phenytoin Oral Suspension USP, 125 mg/5 mL potency, 8 fl oz (237 mL) Rx Only Mfd. by: Taro Pharmaceuticals Industries Ltd. Haifa Bay, Israel 2624761 Dist. by: Taro Pharmaceuticals U.S.A. Inc. Hawthorne, NY 10532, NDC 51672-4069-1. Recalled by Taro Pharmaceuticals U.S.A., Inc.. Units affected: 29,172 8 Fl Oz bottles.
Why was this product recalled?
Resuspension Problems: Two lots of Phenytoin Oral Suspension USP 125mg/5mL may coagulate and may not resuspend as per the label copy instructions.
Which agency issued this recall?
This recall was issued by the FDA Drug on March 4, 2020. Severity: Critical. Recall number: D-0863-2020.